Celiac Disease: Symptoms, Diagnostic Tests and 2026 Biopsy Guidelines

Evidence reviewed: 8 November 2026. Celiac disease (coeliac disease) is an immune-mediated disorder in which eating gluten from wheat, barley or rye triggers inflammation and injury in the small intestine in genetically susceptible people. It can cause diarrhea, bloating, anemia or weight loss, but some patients have few digestive symptoms. Accurate diagnosis is important because treatment generally requires a lifelong gluten-free diet. Do not stop eating gluten before diagnostic blood tests or biopsy unless your clinician advises you to: doing so may make the tests falsely negative [1–3].

What happens in celiac disease?

Gluten contains proteins that are incompletely digested in the intestine. In a susceptible person, the enzyme tissue transglutaminase 2 (TG2) modifies some gluten peptides, allowing them to be presented to T cells by HLA-DQ2 or HLA-DQ8 molecules. This can trigger inflammation, an increase in intraepithelial lymphocytes, changes to intestinal crypts and, in established disease, damage to the villi that normally absorb nutrients. These processes may cause deficiencies in iron, folate, vitamin B12, vitamin D and other nutrients [1,2].

Celiac disease is not the same as wheat allergy or non-celiac gluten sensitivity. Wheat allergy is an allergic condition that may produce rapid symptoms, including anaphylaxis. Non-celiac gluten sensitivity describes symptoms associated with gluten-containing foods without evidence of celiac disease or wheat allergy; other wheat components, such as fructans, may contribute. A specific celiac diagnostic evaluation is therefore valuable before making a permanent dietary change.

Common symptoms and reasons for testing

  • Gastrointestinal: chronic or recurrent diarrhea, abdominal pain, bloating, loose or fatty stools, constipation or unexplained weight loss.
  • Nutritional: iron-deficiency anemia, folate deficiency, fatigue or reduced bone mineral density.
  • Other manifestations: dermatitis herpetiformis (an intensely itchy blistering rash), mouth ulcers or unexplained elevated liver enzymes.
  • Children: poor growth, delayed puberty, abdominal symptoms or nutritional deficiencies.
  • Higher-risk groups: first-degree relatives of a person with celiac disease and individuals with type 1 diabetes or selected autoimmune conditions may merit testing [1–3].

Symptoms alone do not establish celiac disease. Irritable bowel syndrome, inflammatory bowel disease, lactose intolerance, medication effects and other malabsorption conditions can appear similar. Severe dehydration, bloody stools, marked weight loss or other alarm features require appropriate evaluation, not only a gluten-free trial.

What is the preferred first blood test?

In adults and many children, first-line testing uses IgA anti–tissue transglutaminase (tTG-IgA) together with total serum IgA. Measuring total IgA matters because a patient with selective IgA deficiency may have a falsely negative IgA-based antibody result. In that situation, a clinician considers IgG-based tests, such as IgG tTG or IgG deamidated gliadin peptide (DGP), and usually endoscopic biopsy when appropriate [1,2].

The 2026 British Society of Gastroenterology (BSG) and 2025 European Society for the Study of Coeliac Disease (ESsCD) guidance emphasize that antibody tests must be interpreted while the person consumes gluten, using a validated assay and clinical history [1,2]. IgG antigliadin antibody testing from older panels is not a recommended stand-alone diagnostic strategy.

How is celiac disease confirmed?

Traditionally, a specialist combines characteristic serology with upper gastrointestinal endoscopy and multiple duodenal biopsies. Because mucosal injury can be patchy, taking only one sample may miss disease. The 2026 BSG guideline recommends at least four biopsies from the second portion of the duodenum and two from the duodenal bulb when biopsy is indicated [1]. Histology is interpreted with antibodies, symptoms and alternative causes of villous atrophy, rather than in isolation.

Clinical situation Diagnostic approach
Suspected celiac disease, eating gluten tTG-IgA plus total IgA, followed by specialist review and often duodenal biopsy.
IgA deficiency Use appropriate IgG-based serology; biopsy is generally important if suspicion persists.
Strong symptoms despite negative serology Evaluate other causes; endoscopy and biopsy may still be appropriate, especially with malabsorption or alarm features.
Already gluten-free Discuss HLA testing or a supervised gluten challenge rather than interpreting negative antibodies as definitive.
Very high tTG-IgA in a selected adult In certain specialist settings, a no-biopsy pathway may be offered under current European/UK criteria [1,2].

What changed in the 2026 BSG no-biopsy recommendations?

The July 2026 BSG guideline permits an optional no-biopsy diagnosis in symptomatic adults assessed in secondary (specialist) care when tTG-IgA is at least 10 times the laboratory assay’s upper limit of normal (ULN), under quality-assured testing and shared decision-making [1]. It is not a general permission for primary-care self-diagnosis from a positive antibody test. Endoscopy remains important when there are red flags, another reason for endoscopy, autoimmune test interference, or diagnostic uncertainty.

The 2025 ESsCD guidance also supports no-biopsy diagnosis in some adults with tTG-IgA at least 10 times ULN, but specifies confirmation in a second blood sample. This difference between guideline pathways illustrates why clinicians should follow local protocols and assay requirements rather than mixing different rules [2]. The 2023 American College of Gastroenterology guideline generally favors duodenal biopsy confirmation in adults while acknowledging particular circumstances where a likely diagnosis may be made without it [3].

What if the person already stopped gluten?

Antibody levels and intestinal inflammation may fall after removing gluten, which complicates diagnosis. The 2026 BSG guidance recommends a specialist-guided gluten challenge of approximately 3–6 g of gluten daily for at least six weeks when required and medically appropriate [1]. Do not attempt this without advice if symptoms are severe, pregnancy is involved or other significant conditions exist. The exact plan varies by age, prior tests, symptom tolerance and clinical risk.

HLA-DQ2/DQ8 testing may be helpful in selected uncertain situations. A negative result for the relevant disease-associated variants makes celiac disease very unlikely; however, a positive result cannot diagnose it, because these variants are also common in people without disease [2,3].

What does a confirmed diagnosis mean for treatment?

The established treatment is a strict lifelong gluten-free diet, ideally with an experienced dietitian. Eliminating wheat, barley and rye—including hidden ingredients and cross-contact—is necessary, but the dietary plan must also remain nutritionally adequate. Most patients improve with suitable adherence; time to complete intestinal healing can vary substantially, especially in adults [1,3].

No routine prescription medicine reverses celiac autoimmunity while allowing continued gluten consumption. Corticosteroids or immunosuppressants are not standard care for uncomplicated disease, and the original article’s generalized claims about oral drug absorption and automatic medicine dose increases were unsupported. In severe malabsorption or when response to a critical medicine changes, clinicians should assess the actual medicine and clinical monitoring needs individually.

Which nutrient and health checks may be needed?

At diagnosis, clinicians should consider iron, folate, B12, vitamin D, calcium and bone health, particularly when there is anemia or malabsorption. The 2026 BSG guideline recommends monitoring relevant nutritional deficiencies and suggests an initial DXA bone-density scan about one year after beginning a gluten-free diet in newly diagnosed adults [1]. Decisions may vary by country and patient risk.

Symptoms, dietetic assessment and selected serologic tests help monitor response, but normal symptoms or antibodies do not reliably prove mucosal healing. Repeat biopsy may be considered depending on the clinical picture, risk factors and shared decisions. Persistent symptoms may be caused by ongoing gluten exposure, lactose intolerance, IBS, microscopic colitis or rarely refractory celiac disease, and deserve reassessment [1].

Celiac disease versus wheat allergy versus IBS

Condition Key distinction
Celiac disease Immune-mediated enteropathy involving gluten; diagnosed by specific serology and often biopsy while consuming gluten.
Wheat allergy Allergic reaction to wheat proteins; may cause rapid hives, swelling, wheezing or anaphylaxis, evaluated through an allergy pathway.
IBS Disorder of gut–brain interaction with recurrent abdominal pain and altered stools, without celiac immune injury.
Non-celiac gluten sensitivity Symptom association after celiac disease and wheat allergy are excluded; no accepted celiac-style villous injury diagnostic marker.

Frequently asked questions

Should I stop eating bread before a celiac blood test?

No. Continue a gluten-containing diet until the diagnostic plan is agreed; premature restriction can cause misleadingly negative tests [1,2].

Is a positive tTG-IgA enough to diagnose every adult?

No. Some carefully selected adults can use a specialist no-biopsy pathway, but most patients still need appropriate specialist evaluation and many need biopsies.

Does HLA-DQ2 mean I have celiac disease?

No. These genetic variants increase susceptibility but are not sufficient to make a diagnosis.

Can celiac disease cause iron deficiency without diarrhea?

Yes. Unexplained anemia is an important reason to consider testing [1,3].

Is a gluten-free trial a reliable diagnostic test?

No. Feeling better without gluten does not distinguish celiac disease from changes in fructan intake or other conditions.

Key takeaways

Test while eating gluten, start with tTG-IgA plus total IgA, and use specialist interpretation. In 2026 a no-biopsy diagnosis is appropriate for selected symptomatic adults under defined conditions, not for everyone. Once confirmed, lifelong gluten avoidance and nutritional follow-up remain central.

For meals, labeling, oats and avoiding cross-contact, read our practical gluten-free living guide.

References

  1. British Society of Gastroenterology. The 2026 BSG guidelines on the diagnosis and management of adult coeliac disease. Gut. 2026. doi:10.1136/gutjnl-2025-337747.
  2. European Society for the Study of Coeliac Disease. 2025 updated guidelines on the diagnosis and management of coeliac disease in adults: diagnostic approach. United European Gastroenterol J. 2025.
  3. American College of Gastroenterology. Diagnosis and management of celiac disease: 2023 ACG guideline recommendations. 2023.
  4. National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of celiac disease. NIH; accessed 8 Nov 2026.

Medical disclaimer: This article is for education and is not a diagnostic service. Do not begin a permanent gluten-free diet before completing appropriate testing when celiac disease is suspected. Diagnostic and dietary decisions must be individualized by clinicians.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *